NEUROMODULATION: VISION 2010 North American Neuromodulation Society 14 th Annual Meeting

1. NEUROMODULATION: VISION 2010 North American Neuromodulation Society 14th Annual Meeting PRESIDENTIAL ADDRESS Robert D. Foreman, PhD, FAHA

2. International Working Group on Neurocardiology Collaboration between Basic Scientists and Physicians UNITED STATES Jeffrey L. Ardell, PhD Pharmacologist UNITED STATES Robert D. Foreman, PhD Neurophysiologist SWEDEN Bengt Linderoth, MD, PhD Neurosurgeon CANADA Rene Cardinal Cardiovascular Pharmacologist CANADA J. Andrew Armour, MD, PhD Cardiovascular Physiologist NETHERLANDS Mike J.L. DeJongste, MD, PhD Cardiologist

3. There are risks and costs to a program of action. But they are Far less than the long-range risks and costs of comfortable inaction John F. Kennedy

4. Greatness is not in where e stand, but in what direction we are Moving. We must sail sometimes with the wind and sometimes against it—but sail we must and not drift, nor lie at anchor. Oliver Wendell Holmes

6. NANS STRATEGIC PLANNING OCTOBER WEEKEND 2009

8. NANS Mission Statement MISSION STATEMENT: The North American Neuromodulation Society (NANS) is dedicated to being the premier organization representing neuromodulation. NANS promotes multidisciplinary collaboration among clinicians, scientists, engineers, and others to advance neuromodulation through education, research, innovation and advocacy. Through these efforts NANS seeks to promote and advance the highest quality patient care.

9. NANS will work to expand the scope of neuromodulation as new technologies and treatments become available. NANS will work to expand the breadth of its membership to involve all disciplines that develop and deliver neuromodulation therapies. NANS will strive to ensure that its’ clinician members are recognized as the pre-eminent providers of quality care to patients who may benefit from neuromodulation therapies. NANS will be its members’ principal resource for continuing education, professional interaction and clinical strategies to promote optimal utilization of neuromodulation therapies. NANS will develop, disseminate, and maintain guidelines that promote patient safety, cost effectiveness, and appropriate patient selection for neuromodulation therapies. NANS will promote awareness and advocate for neuromodulation therapies through its communications and interactions with the public, media, government, medical communities, and third party payers. NANS will work with other societies, government, third party payers, and patients to maintain access to neuromodulation therapies. NANS will promote and support clinical and basic science research to improve the understanding of the mechanisms, expand the scope of, and enhance the evidence base support for the use of neuromodulation therapies. NANS Vision Statement

10. 2010 Achievements • Successful 2010 Annual Meeting • Successful co-sponsorship of Capital Hill and Legislative visits at 2010 ASIPP Annual Meeting • Joint cadaver course with ASIPP • NTAC Leadership Forum

13. 2010 NEUROMODULATION LEADERSHIP FORUM November 5-7, 2010 David Kloth Josh Prager Todd Sitzman Aaron Colodney Eric Hauth NTAC Director Provided 20 potential new leaders with intensive political advocacy and public relation training NANS, ISIS, ASIPP, AAPM, And AANS put aside societal allegiance for the common goal of advocating for continued/improved access to all pain therapies.  

14. NANS 2011 Goals • Expanding the Scope of the Society • Expand/Diversify Membership • Position NANS as the “Go to Society” for all things related to Neuromodulation • Enhance Member Education • Educational Guideline development • Advocacy • Promote better access to care • Research